Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins

Nonfiction, Health & Well Being, Medical, Medical Science, Immunology, Pharmacology
Cover of the book Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319468778
Publisher: Springer International Publishing Publication: April 7, 2017
Imprint: Springer Language: English
Author:
ISBN: 9783319468778
Publisher: Springer International Publishing
Publication: April 7, 2017
Imprint: Springer
Language: English

This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities.

The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book describes the newest developments in antibody drug conjugates and immunotoxins, paving their way to clinical application. Lessons learned from the current state of the art are used to further improve our understanding of their mechanisms of action and off target activities.

The book introduces scientists to all of the prerequisites that must be properly addressed, including identification of the right target, specific traits of target binding antibodies, proper selection of the toxic payload, internalization induced by binding, and next generation conjugation and linker technologies. These knowledge-based, revolutionary new drug principles will form the cornerstone of the future standard of care and will lead to major advances in application, as well as improved quality of life and patient survival rates. This book will be of interest to biotech companies and researchers working in the fields of immunology, pharmacology, and oncology.

More books from Springer International Publishing

Cover of the book Advances in Usability, User Experience and Assistive Technology by
Cover of the book Environment, Energy and Climate Change II by
Cover of the book Fast Electrochemical Impedance Spectroscopy by
Cover of the book Management of Network Organizations by
Cover of the book A Time-Release History of the Opioid Epidemic by
Cover of the book Theory and Practice of Gearing and Transmissions by
Cover of the book Integrated Formal Methods by
Cover of the book Lymphedema by
Cover of the book Graph Theory by
Cover of the book Single-Molecule Fluorescence Spectroscopy of the Folding of a Repeat Protein by
Cover of the book Advances in Dynamical Systems and Control by
Cover of the book Food in the Internet Age by
Cover of the book Mobility, Education and Employability in the European Union by
Cover of the book New Trends in E-service and Smart Computing by
Cover of the book An Introduction to Ceramics by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy